Benzinga's Top #PreMarket Gainers
Forest Laboratories (NYSE: FRX) surged 34.46% to $95.99 in the pre-market session after Actavis (NYSE: ACT) announced its plans to buy Forest Labs for $25 billion. Analysts at Morgan Stanley upgraded Forest Labs from Equal-Weight to Overweight.
Insmed (NASDAQ: INSM) shares jumped 8.42% to $18.15 in pre-market trading after dropping 0.78% on Friday.
BlackBerry (NASDAQ: BBRY) shares gained 4.90% to $9.42 in the pre-market on report of Loeb 10 million share stake. FBR Capital upgraded BlackBerry from Underperform to Market Perform.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.